Hongling Li Selected Research

Hongling Li Research Topics

Disease

17	Neoplasms (Cancer) 11/2021 - 01/2009
6	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2011
4	Hepatitis 10/2022 - 01/2013
4	Hypersensitivity (Allergy) 10/2022 - 07/2018
4	Inflammation (Inflammations) 07/2021 - 04/2016
3	Infections 10/2022 - 12/2015
3	Necrosis 01/2020 - 12/2011
3	Dermatitis 01/2020 - 01/2013
2	Colonic Neoplasms (Colon Cancer) 09/2021 - 11/2018
2	Obesity 05/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 03/2020 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 12/2019 - 05/2019
2	Carcinogenesis 01/2019 - 04/2011
2	Metabolic Bone Diseases (Osteopenia) 01/2019 - 05/2016
2	Scoliosis 01/2019 - 01/2019
2	Wounds and Injuries (Trauma) 01/2018 - 01/2015
2	Atherosclerosis 01/2013 - 01/2010
2	Ischemia 02/2003 - 04/2002
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2022
1	Adenocarcinoma 03/2022
1	Body Weight (Weight, Body) 11/2021
1	Colorectal Neoplasms (Colorectal Cancer) 11/2021
1	Colitis-Associated Neoplasms 09/2021
1	Hyperuricemia 07/2021
1	Fibrosis (Cirrhosis) 07/2021
1	Osteolysis 03/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Dysbiosis 01/2021
1	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2020
1	Echinococcosis (Hydatid Cysts) 03/2020
1	Nasopharyngeal Carcinoma 01/2020
1	Cerebral Palsy (Spastic Diplegia) 01/2020
1	Skin Ulcer 01/2019
1	Keloid 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Skin Diseases (Skin Disease) 01/2019

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2021 - 09/2012
5	Trichloroethylene (Trichloroethene)IBA 10/2022 - 01/2013
4	Long Noncoding RNAIBA 05/2021 - 01/2019
4	Pharmaceutical PreparationsIBA 01/2021 - 06/2018
4	MicroRNAs (MicroRNA)IBA 12/2019 - 04/2011
3	CateninsIBA 11/2021 - 04/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2016
2	fibrin fragment D (D-dimer)IBA 10/2022 - 04/2017
2	Schiff Bases (Schiff Base)IBA 11/2021 - 01/2021
2	2-vanillinIBA 11/2021 - 01/2021
2	LigandsIBA 11/2021 - 01/2021
2	VALD-3IBA 11/2021 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 12/2017
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 05/2016
2	Contrast MediaIBA 05/2019 - 01/2009
2	CytokinesIBA 01/2018 - 04/2016
2	Krebs-Henseleit solutionIBA 02/2003 - 04/2002
2	Adenosine Triphosphate (ATP)IBA 02/2003 - 04/2002
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	AutoantibodiesIBA 10/2022
1	Immunoglobulin G (IgG)IBA 10/2022
1	formycin diphosphate (FDP)IBA 10/2022
1	NF-kappa B (NF-kB)IBA 05/2022
1	Glutamate-Cysteine LigaseIBA 03/2022
1	Antineoplastic Agents (Antineoplastics)IBA 11/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 09/2021
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2021
1	Xanthine DehydrogenaseIBA 09/2021
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 07/2021
1	Xanthine OxidaseIBA 07/2021
1	potassium oxonateIBA 07/2021
1	Uric Acid (Urate)IBA 07/2021
1	Polyethylene (Polythene)IBA 03/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	thiazolyl blueIBA 01/2021
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2021
1	Tigecycline (Tygacil)FDA Link 01/2021
1	HLA-B Antigens (HLA-B)IBA 12/2020
1	Trichloroacetic AcidIBA 12/2020
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 03/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2020
1	Albendazole (Albenza)FDA Link 03/2020
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	Translationally-Controlled 1 Tumor ProteinIBA 01/2020
1	2,2,2-trichloroethanolIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	UbiquitinIBA 01/2019
1	diphenyl (biphenyl)IBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019

Therapy/Procedure

3	Therapeutics 01/2019 - 03/2014
2	Aftercare (After-Treatment) 01/2019 - 01/2014
2	Radiotherapy 01/2019 - 04/2017
1	Hip Replacement Arthroplasty (Total Hip Replacement) 03/2021
1	Reoperation 03/2021
1	Heterologous Transplantation (Xenotransplantation) 01/2021
1	Oral Administration 01/2021
1	Hyperbaric Oxygenation 01/2021
1	Transcranial Direct Current Stimulation 01/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2020